Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate (Q33618202)

28 July 2017

title

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate (English)

1 reference

inflammatory bowel diseases

28 July 2017

main subject

0 references

inflammation

0 references

author name string

Schreiber S

1

1 reference

28 July 2017

Hämling J

2

1 reference

28 July 2017

Zehnter E

3

1 reference

28 July 2017

Howaldt S

4

1 reference

28 July 2017

Daerr W

5

1 reference

28 July 2017

Raedler A

6

1 reference

28 July 2017

Kruis W

7

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

28 July 2017

1 reference

28 July 2017

volume

40

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

761-766

1 reference

Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Microalbuminuria in inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Maintenance therapy in ulcerative colitis and Crohn's disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Renal syndromes associated with nonsteroidal antiinflammatory drugs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Rapid differentiation of glomerular and tubular proteinuria by sodium dodecyl sulfate polyacrylamide gel electrophoresis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Nephrotic syndrome after treatment with 5-aminosalicylic acid

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Time to scrap creatinine clearance?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Acute interstitial nephritis due to 5-aminosalicylic acid

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Tests of renal function in patients with quiescent colitis: effects of drug treatment

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Reversible Renal Failure and Nephrotic Syndrome Associated with Nonsteroidal Anti-Inflammatory Drugs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

National Cooperative Crohn's Disease Study: adverse reactions to study drugs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Nephrotoxic lesions from 5-aminosalicylic Acid.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027201

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

30 October 2018

1 reference

12 December 2020

Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979)

1 reference

12 December 2020

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1 reference

12 December 2020

Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples

1 reference

12 December 2020

Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease

1 reference

12 December 2020

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

12 December 2020

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

1 reference

12 December 2020

The effect of massive doses of PAS on renal function and electrolyte balance

1 reference

12 December 2020

[Acute interstitial nephritis caused by 5-aminosalicylic acid?]

1 reference

12 December 2020

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

12 December 2020

Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man

1 reference

12 December 2020

Creatinine clearance: a redundant clinical investigation

1 reference

12 December 2020

The use of urinary N-acetyl-β-glucosaminidase in human renal toxicology II. Elevation in human excretion after aspirin and sodium salicylate

1 reference

12 December 2020

[Nephritis from 5-aminosalicylic acid]

1 reference

12 December 2020

Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group

1 reference

12 December 2020

Assessment of drug nephrotoxicity by the excretion of tubule-specific membrane antigens and enzymes

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.40.6.761

1 reference

28 July 2017

1 reference

28 July 2017

1 reference